Which acronym refers to the Clinical Laboratory Improvement Amendments?

The acronym referring to the Clinical Laboratory Improvement Amendments is CLIA. This legislation, enacted in 1988, established quality standards for laboratory testing to ensure accuracy, reliability, and timeliness of test results, which are crucial for patient care. CLIA encompasses various aspects of laboratory operations, including the certification of laboratory personnel and the establishment of procedures that laboratories must follow to maintain compliance.

The other acronyms represent different organizations and do not relate to the specific regulations governing clinical laboratory testing. The CDC, or Centers for Disease Control and Prevention, focuses on public health and safety issues, while the FDA, or Food and Drug Administration, is responsible for regulating food safety, pharmaceuticals, medical devices, and other health-related products. The WHO, or World Health Organization, is concerned with international public health initiatives and guidelines. Each of these organizations plays a significant role in healthcare, but they do not specifically address the quality and standards set forth in the Clinical Laboratory Improvement Amendments. Thus, CLIA is the correct choice in the context of laboratory regulations.